Prevalence of Gastro-esophageal Reflux Disease and Its Risk Factors Among Medical Students in Medina
Abstract
Background and aim: Gastroesophageal Reflux Disease is one of the most common gastrointestinal disorders presenting in general medical practice which adversely affects the quality of life. We Aimed to determine the prevalence of Gastroesophageal Reflux Disease and its risk factors among medical students in Medina, Saudi Arabia.
Methods: A cross-sectional study was conducted from January to June 2021 using a pre-designed questionnaire distributed among medical students in Medina, Saudi Arabia. The questionnaire was composed of questions regarding sociodemographic and lifestyle characteristics. The diagnosis of Gastroesophageal Reflux Disease was made using the GERDQ questionnaire. The data were analyzed by Statistical Package for Social Sciences version 27.
Results: Out of the 385 participants, the majority were females (65.7%). Based on ≥8 GERDQ score, 14.8% had Gastroesophageal Reflux Disease. The only significant risk factor was family history (36.8%). The prevalence of the remaining factors among the Gastroesophageal Reflux Disease group in the following descending order: skipping breakfast (66.7%), normal body mass index (62.5%), sleeping <7 hours/day (57.9%), fried food (57.9%), coffee and tea intake (50.9%), spicy food (49.1%), eating main meals within 10 min (43.9%), fast food (42.1%), sleeping within <1 hour of dinner (31.6%), exercising 2-3 times/week (26.3%), carbonated drinks (22.8%), smoking (10.5%), and non-steroidal anti-inflammatory drugs use (5.3%).…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 385 participants or records.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.